ICU — Investor Centre Income Statement
0.000.00%
Last trade - 00:00
- AU$7.28m
- AU$9.12m
- AU$1.29m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.851 | 1.31 | 2.32 | 2.94 | 1.29 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.11 | 6.9 | 3.34 | 4.27 | 2.62 |
Operating Profit | -2.26 | -5.59 | -1.02 | -1.33 | -1.33 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.33 | -5.72 | -1.2 | -3.11 | -1.41 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.33 | -5.72 | -1.2 | -3.11 | -1.41 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.33 | -5.72 | -1.2 | -3.11 | -1.41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.33 | -5.72 | -1.2 | -3.11 | -1.41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.028 | -0.02 | -0.015 | -0.028 | -0.007 |